Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Illumina Singapore Pte. Ltd. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, requiring coordination across separate examination settings. HAYES, JONATHAN EDWARD is the busiest examiner, with 1 pending matter.
The profile calls for consistent portfolio positioning alongside examiner-specific prosecution work. Counsel should review claim terminology, disclosure support, and technical arguments across both matters while adapting each response to its assigned art unit. The busiest examiner is responsible for 1 pending matter, and the remaining action is handled by another examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOITACH, JOSEPH T | 1 | 49.5% | +27.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17329069 | Sequencing Process | WOITACH, JOSEPH T | — |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17329069 | Sequencing Process | WOITACH, JOSEPH T | 1687 | DP | Non-Final OA | — | Pending | May 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIllumina Singapore Pte. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joseph T Woitach has the most, with 1 of Illumina Singapore Pte. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
